Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.

Article  CAS  PubMed  Google Scholar 

Qiu X, Shen C, Zhao W, Zhang X, Zhao D, Zhu Y, et al. Prognostic value of the combination of HB (hemoglobin) and CEA in resectable gastric cancer. J Cancer. 2022;13:2246–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40:250–60.

Article  CAS  PubMed  Google Scholar 

Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–48.

Article  CAS  PubMed  Google Scholar 

Yoong J, Michael M, Leong T. Targeted therapies for gastric cancer: current status. Drugs. 2011;71:1367–84.

Article  CAS  PubMed  Google Scholar 

Hashimoto T, Kurokawa Y, Mori M, Doki Y. Update on the treatment of gastric cancer. JMA J. 2018;1:40–9.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhang L, Yang Y, Lu S, Chen H. Progress of gastric cancer surgery in the era of precision medicine. Int J Biol Sci. 2021;17:1041–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen L, Xu JM, Feng FY, Jiao SC, Wang LW, Li J, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport. Zhonghua Zhong Liu Za Zhi. 2013;35:295–300.

CAS  PubMed  Google Scholar 

Nord K, Nilsson J, Nilsson B, Uhlen M, Nygren PA. A combinatorial library of an alpha-helical bacterial receptor domain. Protein Eng. 1995;8:601–8.

Article  CAS  PubMed  Google Scholar 

Nord K, Gunneriusson E, Ringdahl J, Stahl S, Uhlen M, Nygren PA. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat Biotechnol. 1997;15:772–7.

Article  CAS  PubMed  Google Scholar 

Fedorova A, Zobel K, Gill HS, Ogasawara A, Flores JE, Tinianow JN, et al. The development of peptide-based tools for the analysis of angiogenesis. Chem Biol. 2011;18:839–45.

Article  CAS  PubMed  Google Scholar 

Stahl S, Graslund T, Eriksson Karlstrom A, Frejd FY, Nygren PA, Lofblom J. Affibody molecules in biotechnological and medical applications. Trends Biotechnol. 2017;35:691–712.

Article  PubMed  Google Scholar 

Lofblom J, Feldwisch J, Tolmachev V, Carlsson J, Stahl S, Frejd FY. Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett. 2010;584:2670–80.

Article  CAS  PubMed  Google Scholar 

Wikman M, Steffen AC, Gunneriusson E, Tolmachev V, Adams GP, Carlsson J, et al. Selection and characterization of HER2/neu-binding affibody ligands. Protein Eng Des Sel. 2004;17:455–62.

Article  CAS  PubMed  Google Scholar 

Antaris AL, Chen H, Cheng K, Sun Y, Hong G, Qu C, et al. A small-molecule dye for NIR-II imaging. Nat Mater. 2016;15:235–42.

Article  CAS  PubMed  Google Scholar 

Cai Y, Ren J, Jin J, Shao H, Wang P, Cheng K, et al. Novel affibody molecules as potential agents in molecular imaging for MAGE-A3-positive tumor diagnosis. Environ Res. 2023;237: 116895.

Article  CAS  PubMed  Google Scholar 

Xue X, Wang B, Du W, Zhang C, Song Y, Cai Y, et al. Generation of affibody molecules specific for HPV16 E7 recognition. Oncotarget. 2016;7:73995–4005.

Article  PubMed  PubMed Central  Google Scholar 

Zhu S, Zhu J, Song Y, Chen J, Wang L, Zhou M, et al. Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer. Appl Microbiol Biotechnol. 2018;102:7429–39.

Article  CAS  PubMed  Google Scholar 

Graham DK, DeRyckere D, Davies KD, Earp HS. The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. Nat Rev Cancer. 2014;14:769–85.

Article  CAS  PubMed  Google Scholar 

Varnum BC, Young C, Elliott G, Garcia A, Bartley TD, Fridell YW, et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature. 1995;373:623–6.

Article  CAS  PubMed  Google Scholar 

Mukherjee SK, Wilhelm A, Antoniades CG. TAM receptor tyrosine kinase function and the immunopathology of liver disease. Am J Physiol Gastrointest Liver Physiol. 2016;310:G899-905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sasaki T, Knyazev PG, Clout NJ, Cheburkin Y, Gohring W, Ullrich A, et al. Structural basis for Gas6-Axl signalling. EMBO J. 2006;25:80–7.

Article  CAS  PubMed  Google Scholar 

Braunger J, Schleithoff L, Schulz AS, Kessler H, Lammers R, Ullrich A, et al. Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site. Oncogene. 1997;14:2619–31.

Article  CAS  PubMed  Google Scholar 

Scaltriti M, Elkabets M, Baselga J. Molecular pathways: AXL, a membrane receptor mediator of resistance to therapy. Clin Cancer Res. 2016;22:1313–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dent P. Crosstalk between ERK, AKT, and cell survival. Cancer Biol Ther. 2014;15:245–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gay CM, Balaji K, Byers LA. Giving AXL the axe: targeting AXL in human malignancy. Br J Cancer. 2017;116:415–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang H, Liu H, Yan R, Hu M. PI3K/Akt and ERK/MAPK signaling promote different aspects of neuron survival and axonal regrowth following rat facial nerve axotomy. Neurochem Res. 2017;42:3515–24.

Article  CAS  PubMed  Google Scholar 

Sen T, Tong P, Diao L, Li L, Fan Y, Hoff J, et al. Targeting AXL and mTOR pathway overcomes primary and acquired resistance to WEE1 inhibition in small-cell lung cancer. Clin Cancer Res. 2017;23:6239–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu C, Shi H, Wu M, Wei X. A dual MET/AXL small-molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironment. MedComm. 2020;2020(1):103–18.

Article  Google Scholar 

Bae CA, Ham IH, Oh HJ, Lee D, Woo J, Son SY, et al. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma. Gastric Cancer. 2020;23:824–36.

Article  CAS  PubMed  Google Scholar 

Kashyap MK, Abdel-Rahman O. Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma. Mol Cancer. 2018;17:54.

Article  PubMed